Synchronous Triple Primary Gastrointestinal Tract Malignancies: A Case Report.
증례보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
endoscopic submucosal dissection and simultaneous surgical resection of the other two neoplasms
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The patient underwent endoscopic submucosal dissection and simultaneous surgical resection of the other two neoplasms. The patient remained without evidence of recurrence or metastasis at the one-year follow-up.
Multiple primary malignant neoplasms are defined as the occurrence of two or more distinct malignant neoplasms in a single patient.
APA
Rim HM, Rah YM, Kim JS (2025). Synchronous Triple Primary Gastrointestinal Tract Malignancies: A Case Report.. The Korean journal of helicobacter and upper gastrointestinal research, 25(4), 381-384. https://doi.org/10.7704/kjhugr.2025.0058
MLA
Rim HM, et al.. "Synchronous Triple Primary Gastrointestinal Tract Malignancies: A Case Report.." The Korean journal of helicobacter and upper gastrointestinal research, vol. 25, no. 4, 2025, pp. 381-384.
PMID
41382371 ↗
Abstract 한글 요약
Multiple primary malignant neoplasms are defined as the occurrence of two or more distinct malignant neoplasms in a single patient. However, synchronous triple primary malignant neoplasms have rarely been reported. We present the case of a 54-year-old male patient who was referred to our outpatient clinic after abnormal findings were detected during upper gastrointestinal endoscopy screening at a local clinic. Comprehensive evaluation using endoscopy, computed tomography, and positron emission tomography led to the simultaneous diagnosis of early gastric, early esophageal, and sigmoid colon cancers. The patient underwent endoscopic submucosal dissection and simultaneous surgical resection of the other two neoplasms. The patient remained without evidence of recurrence or metastasis at the one-year follow-up.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Association of preoperative frailty and prognostic nutritional index with postoperative delirium in elderly gastric cancer patients: A single-center observational study.
- Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.
- Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis.
- Correction: Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012-2023).